Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Speech pause distribution as an early marker for Alzheimer’s disease

View ORCID ProfilePatricia Pastoriza-Domínguez, View ORCID ProfileIván G. Torre, View ORCID ProfileFaustino Diéguez-Vide, Isabel Gómez-Ruiz, Sandra Geladó, Joan Bello-López, Asunción Ávila-Rivera, View ORCID ProfileJordi Matías-Guiu, View ORCID ProfileVanesa Pytel, View ORCID ProfileAntoni Hernández-Fernández
doi: https://doi.org/10.1101/2020.12.28.20248875
Patricia Pastoriza-Domínguez
aDepartament de Filologia Catalana i Lingüística General, Universitat de Barcelona. Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patricia Pastoriza-Domínguez
  • For correspondence: p.pastoriza.dominguez{at}gmail.com
Iván G. Torre
bVicomtech Foundation, Basque Research and Technology Alliance (BRTA). San Sebastian, Spain
gComplexity and Quantitative Linguistics Lab, Institut de Ciències de l’Educació, Universitat Politécnica de Catalunya. Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Iván G. Torre
Faustino Diéguez-Vide
aDepartament de Filologia Catalana i Lingüística General, Universitat de Barcelona. Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Faustino Diéguez-Vide
Isabel Gómez-Ruiz
cHospital General de l’Hospitalet de Llobregat. l’Hospitalet de Llobregat, Spain
dHospital Moisés Broggi, Sant Joan Despí
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Geladó
eUniversitat de Vic - Universitat Central de Catalunya. Vic, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joan Bello-López
cHospital General de l’Hospitalet de Llobregat. l’Hospitalet de Llobregat, Spain
dHospital Moisés Broggi, Sant Joan Despí
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asunción Ávila-Rivera
cHospital General de l’Hospitalet de Llobregat. l’Hospitalet de Llobregat, Spain
dHospital Moisés Broggi, Sant Joan Despí
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jordi Matías-Guiu
fDepartment of Neurology. Hospital Clinico San Carlos. San Carlos Institute for Health Research (IdISSC). Universidad Complutense. Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jordi Matías-Guiu
Vanesa Pytel
fDepartment of Neurology. Hospital Clinico San Carlos. San Carlos Institute for Health Research (IdISSC). Universidad Complutense. Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vanesa Pytel
Antoni Hernández-Fernández
gComplexity and Quantitative Linguistics Lab, Institut de Ciències de l’Educació, Universitat Politécnica de Catalunya. Barcelona, Spain
hSocietat Catalana de Tecnologia, Secció de Ciències i Tecnologia, Institut d’Estudis Catalans. Barcelona, Catalonia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Antoni Hernández-Fernández
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Pause duration analysis is a common feature in the study of discourse in Alzheimer’s disease (AD) and may also be helpful for its early detection. However, studies involving patients with amnestic mild cognitive impairment (aMCI) have yielded varying results.

Objectives To characterize the probability density distribution of speech pause durations in AD, two multi-domain amnestic MCI patients (with memory encoding deficits, a-mdMCI-E, and with retrieval impairment only, a-mdMCI-R) and healthy controls (HC) in order check whether there are significant differences between them.

Method 112 picture-based oral narratives were manually transcribed and annotated for the automatic extraction and analysis of pause durations. Different probability distributions were tested for the fitting of pause durations while truncating shorter ranges. Recent findings in the field of Statistics were considered in order to avoid the inherent methodological uncertainty that this type of analysis entails.

Results A lognormal distribution (LND) explained the distribution of pause duration for all groups. Its fitted parameters (µ,σ) followed a gradation from the group with shorter durations and a higher tendency to produce short pauses (HC) to the group with longer pause durations and a considerably higher tendency to produce long pauses with greater variance (AD). Importantly, a-mdMCI-E produced significantly longer pauses and with greater variability than their a-mdMCI-R counterparts (α = 0.05).

Conclusion We report significant differences at the group level in pause distribution across all groups of study that could be used in future diagnostic tools and discuss the clinical implications of these findings, particularly regarding the characterization of aMCI.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work is supported through a PhD grant awarded to P.P-D. by the banking Foundation "La Caixa" (ID 100010434, code: LCF/BQ/ES15/10360020). F.D-V. was supported by a grant awarded to project no. PID2019-107042GB-I00 (Ministerio de Ciencia e Innovacion). A.H-F. and I.G.T. were supported by the grant no. TIN2017-89244-R (MACDA, Ministerio de Economia, Industria y Competitividad, Gobierno de Espana) and the project PRO2020-S03 (RCO03080 Linguistica Quantitativa) of l'Institut d'Estudis Catalans.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was assessed and approved by the Bioethics Committee of Universitat de Barcelona (IRB00003099), by the clinical research ethics committee of Hospital Clinico San Carlos (ref. 19/046-E) and by the clinical research ethics committee of the Consorci Sanitari Integral-Hospital Universitari de Bellvitge in the case of Hospital General de l'Hospitalet de Llobregat (ref. 19/43-PR222/19). All participants signed a written informed consent form prior to enrollment in the study.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The speech pauses duration corpus used in this study and scripts that ensure reproducibility of all results are public available in https://github.com/ivangtorre/Speech-pause-distribution-as-an-early-marker-for-Alzheimers-disease. The full complete corpus may be accessible under some considerations upon request to the main author. We have used Python 3.8.2 and R 3.6.3 for the analysis. MLE fit, Kolmogorov-Smirnov AIC and BIC make use of fitdistrplus 1.1.1 and truncdist 1.0.2. Numpy, Pandas and Matplotlib libraries are also used. Some other statistical analyses were performed on IBM SPSS 25.0. Replicability of the study is addressed through Section 1 (Material and Methods) of the present paper.

https://github.com/ivangtorre/Speech-pause-distribution-as-an-early-marker-for-Alzheimers-disease

https://github.com/PatriciaPast/Speech-pause-distribution-as-an-early-marker-for-Alzheimers-disease

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted January 04, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Speech pause distribution as an early marker for Alzheimer’s disease
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Speech pause distribution as an early marker for Alzheimer’s disease
Patricia Pastoriza-Domínguez, Iván G. Torre, Faustino Diéguez-Vide, Isabel Gómez-Ruiz, Sandra Geladó, Joan Bello-López, Asunción Ávila-Rivera, Jordi Matías-Guiu, Vanesa Pytel, Antoni Hernández-Fernández
medRxiv 2020.12.28.20248875; doi: https://doi.org/10.1101/2020.12.28.20248875
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Speech pause distribution as an early marker for Alzheimer’s disease
Patricia Pastoriza-Domínguez, Iván G. Torre, Faustino Diéguez-Vide, Isabel Gómez-Ruiz, Sandra Geladó, Joan Bello-López, Asunción Ávila-Rivera, Jordi Matías-Guiu, Vanesa Pytel, Antoni Hernández-Fernández
medRxiv 2020.12.28.20248875; doi: https://doi.org/10.1101/2020.12.28.20248875

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)